GAIN THERAPEUTICS INC (GANX) Stock Income Statement
USA - NASDAQ:GANX - US36269B1052 - Common Stock
2.83 USD
-0.16 (-5.35%)
2.87 USD
+0.04 (+1.41%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 55.20K | 140.00K | 160.00K | 30.00K | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 20.35M | 22.31M | 17.92M | 13.99M | 3.51M | |||
| Research and Development | 10.65M | 11.38M | 8.38M | 7.16M | 2.26M | |||
| Selling, General, and Administrative Expenses | 9.65M | 10.88M | 9.54M | 6.83M | 1.25M | |||
| Operating Income | -20.35M | -22.25M | -17.78M | -13.83M | -3.48M | |||
| Interest Income/Expense | 476.20K | 64.90K | 280.00K | -60.00K | -90.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -19.87M | -22.19M | -17.50M | -13.89M | -3.57M | |||
| Income Tax | 536.80K | 79.30K | 90.00K | 0 | 10.00K | |||
| Net Income | -20.41M | -22.27M | -17.59M | -13.89M | -3.58M | |||
| EBITDA | -20.27M | -22.17M | -17.72M | -13.81M | -3.47M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.892 | -1.7114 | -1.48 | -1.37 | -0.32 | |||
| Non GAAP EPS | -0.9199999999999999 | -1.78 | -1.48 | -1.51 | null | |||
| Statistics | ||||||||
| Profit Margin | N/A | -40339.67% | -12564.29% | -8681.25% | -11933.33% | |||
| Operating Profit Margin | N/A | -40313.59% | -12700.00% | -8643.75% | -11600.00% | |||
All data in USD